These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7039339)

  • 21. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
    Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraportal administration of neuropeptide Y and hepatic glucose metabolism.
    Nishizawa M; Shiota M; Moore MC; Gustavson SM; Neal DW; Cherrington AD
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1197-204. PubMed ID: 18234742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN.
    Donmoyer CM; Chen SS; Hande SA; Lacy DB; Ejiofor J; McGuinness OP
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E235-43. PubMed ID: 10913021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined intraportal infusion of acetylcholine and adrenergic blockers augments net hepatic glucose uptake.
    Shiota M; Jackson P; Galassetti P; Scott M; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E544-52. PubMed ID: 10710510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.
    Pagliassotti MJ; Holste LC; Moore MC; Neal DW; Cherrington AD
    J Clin Invest; 1996 Jan; 97(1):81-91. PubMed ID: 8550854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin.
    Winnick JJ; An Z; Moore MC; Ramnanan CJ; Farmer B; Shiota M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E358-66. PubMed ID: 19470836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs.
    Chap Z; Ishida T; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1985 Sep; 76(3):1174-81. PubMed ID: 3900134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog.
    Cherrington AD; Diamond MP; Green DR; Williams PE
    Diabetes; 1982 Oct; 31(10):917-22. PubMed ID: 6759225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
    An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man.
    Jackson RA; Hamling JB; Blix PM; Sim BM; Hawa MI; Jaspan JB; Belin J; Nabarro JD
    J Clin Endocrinol Metab; 1986 Sep; 63(3):594-604. PubMed ID: 2874153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.
    Pencek RR; Shearer J; Camacho RC; James FD; Lacy DB; Fueger PT; Donahue EP; Snead W; Wasserman DH
    Diabetes; 2005 Feb; 54(2):355-60. PubMed ID: 15677492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural and pancreatic influences on net hepatic glucose uptake and glycogen synthesis.
    Moore MC; Rossetti L; Pagliassotti MJ; Monahan M; Venable C; Neal D; Cherrington AD
    Am J Physiol; 1996 Aug; 271(2 Pt 1):E215-22. PubMed ID: 8770013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo.
    An Z; Winnick JJ; Farmer B; Neal D; Lautz M; Irimia JM; Roach PJ; Cherrington AD
    Diabetes; 2010 Dec; 59(12):2999-3007. PubMed ID: 20823104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.
    Moore MC; Kimura K; Shibata H; Honjoh T; Saito M; Everett CA; Smith MS; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E225-31. PubMed ID: 15755767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog.
    Shulman GI; Williams PE; Liljenquist JE; Lacy WW; Keller U; Cherrington AD
    Metabolism; 1980 Apr; 29(4):317-20. PubMed ID: 6103495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.